1. Home
  2. Stocks
  3. Advikla Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • MPS Pharma

    Small Cap
    ₹3.66
    27 July, 2024 10:25 BSE: 531686 NSE: ADVIKLA ISIN: INE537C01019

    Start SIP in MPS Pharma

    Start SIP

    MPS Pharma Performance

    Day Range

    • Low 0
    • High 0
    ₹ 3

    52 Week Range

    • Low 0
    • High 0
    ₹ 3
    • Open Price0
    • Previous Close0
    • Volume

    MPS Pharma Share Price

    • Over 1 Month + 4.87%
    • Over 3 Month + 14.02%
    • Over 6 Month + 25.34%
    • Over 1 Year + 51.24%

    MPS Pharma Key Statistics

    MPS Pharma Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 00000
    Operating Expenses Qtr Cr 00000
    Operating Profit Qtr Cr 00000
    Depreciation Qtr Cr 00000
    Interest Qtr Cr 00000
    Tax Qtr Cr 00000
    Net Profit Qtr Cr 00000
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 00
    Operating Expenses Annual Cr 11
    Operating Profit Annual in Cr -1-1
    Depreciation Cr 00
    Interest Annual Cr 00
    Tax Annual Cr 00
    Net Profit Annual Cr -1-1
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -1-1
    Cash from Investing Activity Annual Cr 00
    Cash from Financing Annual Activity Cr 11
    Net Cash Flow Annual Cr 00
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 23
    Fixed Assets Annual Cr 78
    Total Non Current Assets Annual Cr 88
    Total Current Assets Annual Cr 22
    Total Assets Annual Cr 1010
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 11
    ROE Annual % -42-38
    ROCE Annual % -39-35
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 00
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Invest in MPS Pharma

    MPS Pharma Technicals

    EMA & SMA

    Current Price
    ₹3.66
    + 0 (0%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹3.35
    • 50 Day
    • ₹2.97
    • 100 Day
    • ₹2.50
    • 200 Day
    • ₹2.10
    • 20 Day
    • ₹3.34
    • 50 Day
    • ₹2.94
    • 100 Day
    • ₹2.38
    • 200 Day
    • ₹1.54

    MPS Pharma Resistance and Support

    PIVOT
    ₹3.66
    Resistance
    First Resistance 3.66
    Second Resistance 3.66
    Third Resistance 3.66
    RSI 97.32
    MFI 85.68
    MACD Single Line 0.19
    MACD 0.20
    Support
    First Support 3.66
    Second Support 3.66
    Third Supoort 3.66

    MPS Pharma Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 2,500 250,000 100
    Week 2,500 250,000 100
    1 Month
    6 Month 1,985 198,480 100

    MPS Pharma Result Highlights

    MPS Pharma Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    MPS Pharma Corporate Action

    Date Purpose Remarks
    2024-05-30 Audited Results
    2024-03-26 Independent Director Meeting
    2024-02-13 Quarterly Results
    2023-11-09 Quarterly Results
    2023-08-12 Quarterly Results

    MPS Pharma MF Shareholding

    Name Amount(cr)

    MPS Pharma FAQs

    What is Share Price of MPS Pharma ?

    MPS Pharma share price is ₹3 As on 27 July, 2024 | 10:11

    What is the Market Cap of MPS Pharma ?

    The Market Cap of MPS Pharma is ₹7 Cr As on 27 July, 2024 | 10:11

    What is the P/E ratio of MPS Pharma ?

    The P/E ratio of MPS Pharma is -8.4 As on 27 July, 2024 | 10:11

    What is the PB ratio of MPS Pharma ?

    The PB ratio of MPS Pharma is 3.6 As on 27 July, 2024 | 10:11

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.